Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2012
09/05/2012CN101906404B Avian infectious bronchitis virus (IBV) as well as culture method and application thereof
09/05/2012CN101905020B Method for producing swine fever vaccines
09/05/2012CN101838318B Anti-HIV-I polypeptide and coding sequence and use thereof
09/05/2012CN101816786B Inactivated hepatitis A vaccine and preparation method thereof
09/05/2012CN101804194B CTLA4lg and derivatives thereof used for resisting bacteria
09/05/2012CN101804044B Abietate used for inhibiting helicobacter pylori
09/05/2012CN101792375B Sesquiterpene compound in tobacco stems and preparation method and application thereof
09/05/2012CN101785786B Chlorine dioxide ointment used for treating dermatophytosis
09/05/2012CN101775399B Asia1 type multi-epitope recombinant vaccine of bovine foot-and-mouth disease viruses and preparation method thereof
09/05/2012CN101773478B Pulmonary targeting microsphere of veterinary ceftiofur hydrochloride and preparation method thereof
09/05/2012CN101756955B Chinonin complex, preparation method and application thereof
09/05/2012CN101756909B Lung-targeting ceftiofur microsphere and preparation method thereof
09/05/2012CN101756016B Natural plant preparation for preventing animal diarrhea and preparation method thereof
09/05/2012CN101745108B Avian influenza vaccine and preparation method thereof
09/05/2012CN101744831B Preparation method of tylosin tartrate-doxycycline hydrochloride pharmaceutical composition
09/05/2012CN101744830B Flavonoid compound and application of plant extract containing same
09/05/2012CN101732604B Siberian cocklour and Indian kalimeris herb soup for treating mumps
09/05/2012CN101730698B Compounds for the treatment of hepatitis c
09/05/2012CN101717754B Enterovirus type 71 and use thereof
09/05/2012CN101716179B Anti-hepatitis B pharmaceutical composition, preparation method and applications thereof
09/05/2012CN101684116B Isoniazid lipid derivate and compositions thereof
09/05/2012CN101671367B Pleuromutilin phosphate compounds, medicinal composition thereof, preparation method thereof and application thereof
09/05/2012CN101648994B Azepine argireline or pharmaceutically acceptable salt thereof and preparation method and application thereof
09/05/2012CN101642570B Application of carbon monoxide-releasing molecules and heparin in preparing medicament for treating sepsis
09/05/2012CN101633907B Amplification culture method for antigen specific cytotoxic t lymphocytes
09/05/2012CN101626779B Oral disinfectant, food additive comprising the disinfectant
09/05/2012CN101597281B Preparation method of lamivudine and intermediate thereof
09/05/2012CN101568538B Thiophene analogues for the treatment or prevention of flavivirus infections
09/05/2012CN101543594B Mulberry-chrysanthemum oral liquid
09/05/2012CN101534838B Use of c7 sugars in prevention and treatment of mycoses
09/05/2012CN101497877B Influenza all-virus attenuated live vaccine recombinant, construction method and use thereof
09/05/2012CN101495128B Isolated extract of walnuts, process for its obtaining and its use
09/05/2012CN101487010B Method for preparing vaccine for anti-HPV 18 infection by pichia yeast expression system
09/05/2012CN101485788B Pu'er tea and application of preparation thereof in preventing and treating pestis
09/05/2012CN101468201B Preparation of Mycobacterium tuberculosis polyvalent recombinant protein vaccine
09/05/2012CN101466683B Inhibitors of AKT (protein kinase B)
09/05/2012CN101448499B Use of cantffln-6-ketone and its analogues in the treatment of pathologies linked to mycobacteria
09/05/2012CN101433537B External-use spray for resisting mycotic infection of superficial part and preparation method thereof
09/05/2012CN101386593B Norfloxacin glutamate hydrate and preparation and use thereof
09/05/2012CN101360752B Hiv integrase inhibitors
09/05/2012CN101342148B Quick-effective antimicrobial, anti-inflammation, antiviral hyperconcentrated natural allicin tablet and preparation method thereof
09/05/2012CN101300250B Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
09/05/2012CN101279970B 2-methyl-5-azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutied derivate, preparation and application thereof
09/05/2012CN101240032B Broad spectrum influenza virus resistant antagonistic peptide nasal spray preparation and application
09/05/2012CN101168560B N-substituted peptide amide, pharmaceutical composition and use thereof
09/05/2012CN101167799B Scutellaria barbata total flavone and its application in preparing influenza virus resisting medicine
09/05/2012CN101130060B Medical composition containing dalbavancin
09/05/2012CN101111475B Antiviral compounds and methods
09/05/2012CN101006172B Anticancer agent containing dendritic cell having RNA virus transferred thereinto
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258262 N-terminally chemically modified protein compositions and methods
09/04/2012US8258120 9-substituted minocycline compounds
09/04/2012US8258106 Immunostimulatory nucleic acid molecules
09/04/2012US8257745 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
09/04/2012US8257714 Compositions and methods for immunotherapy of cancer and infectious diseases
09/04/2012US8257478 Use of marine fungus originated compounds as antifouling agents
09/04/2012CA2615022C Hcv ns3 protease inhibitors
09/04/2012CA2414339C Bvdv virus-like particles
09/04/2012CA2384437C Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis
09/03/2012CA2734014A1 Cold sore formulation and related method of manufacture
08/2012
08/30/2012WO2012116370A1 Methods and systems using pharmacokinetic and pharmacodynamic profiles in interferon-alpha therapeutic regimens
08/30/2012WO2012116280A2 Formulations useful for spray drying vaccines
08/30/2012WO2012116257A1 Anti-viral compounds
08/30/2012WO2012116010A2 Antibiotic tolerance inhibitors
08/30/2012WO2012115256A1 C-4" position substituted macrolide derivative
08/30/2012WO2012115241A1 Fcγriib-specific fc antibody
08/30/2012WO2012115159A1 Polypeptide compound
08/30/2012WO2012115118A1 Polypeptide compound
08/30/2012WO2012114355A1 Novel process for preparation of linezolid and its novel intermediates
08/30/2012WO2012113920A1 Arylsulfone derivatives with activity against human betaherpesviruses
08/30/2012WO2012113891A1 Use of polyaminoisoprenyl derivatives in antibiotic or antiseptic treatment
08/30/2012WO2012113850A2 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
08/30/2012WO2012113594A1 Use of nifuratel to treat infections caused by clostridium species
08/30/2012WO2012113348A1 Anti-cd4 protein monoclonal antibody, active fragments and uses thereof
08/30/2012WO2012113343A1 Use of il-17 inhibitor in preparation of drug for treating and/or preventing lung injury
08/30/2012WO2012094540A3 Methods for preparation of glycosphingolipids and uses thereof
08/30/2012WO2012092157A3 Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
08/30/2012WO2012091081A8 Interferon production-inducing agent containing lactic acid bacteria
08/30/2012WO2012073214A3 Heptose derivatives for use in the treatment of bacterial infections
08/30/2012US20120220667 Use of methylsulfonylmethane (msm) to inhibit microbial activity
08/30/2012US20120220658 Method for Treating Sepsis or Septic Shock
08/30/2012US20120220633 Piperidine derivatives as human papilloma virus inhibitors
08/30/2012US20120220631 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR
08/30/2012US20120220620 Antitubercular alkaloid
08/30/2012US20120220599 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
08/30/2012US20120220571 Hiv integrase inhibitors
08/30/2012US20120220566 Antimicrobial Compounds and Methods of Making and Using the Same
08/30/2012US20120220562 Anti-Viral Compounds
08/30/2012US20120220559 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/30/2012US20120220520 Bioavailable combinations for hcv treatment
08/30/2012US20120220519 Peptide Aptamers that Bind to the Rep Proteins of ssDNA Viruses
08/30/2012US20120220518 Therapeutic agent delivery system and method
08/30/2012US20120220457 IMIDAZO [1,2-a]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME
08/30/2012US20120219648 Picrorhiza kurroa extract for prevention, elimination and treatment of dna based viruses in humans and in biotech industry
08/30/2012US20120219644 Coconut oil-based intranasal composition and use
08/30/2012US20120219640 Anti-infective solution for athlete's foot
08/30/2012US20120219625 Clarithromycin extended-release tablet
08/30/2012US20120219624 Process for preparing products comprising stabilised actives and compositions comprising same
08/30/2012US20120219620 SCF Extract Containing Cardiac Glycoside
08/30/2012US20120219616 LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 1798